Journal of Neuroinflammation · 2019 · 154 citations · 38 references
MedicineNeurologyNeuroscienceDementiaMolecular NeuroscienceNeuropharmacologyAlzheimer DiseaseCognitive ImpairmentNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationNeuroprotectionAlzheimer Disease DementiaAlzheimer's Disease ModelsAnti-inflammatory ActivityAnti-inflammatory ResponseComplementary MedicineMicroglia ActivationMicroglial NeurodegenerationNeuroinflammation In Alzheimer Disease
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive abilities and memory leading to dementia. Electroacupuncture (EA) is a complementary alternative medicine approach, applying an electrical current to acupuncture points. In clinical and animal studies, EA causes cognitive improvements in AD and vascular dementia. However, EA-induced changes in cognition and microglia-mediated amyloid β (Aβ) degradation have not been determined yet in AD animals. Therefore, this study investigated the EA-induced molecular mechanisms causing cognitive improvement and anti-inflammatory activity in five familial mutation (5XFAD) mice, an animal model of AD. METHODS: 5XFAD mice were bilaterally treated with EA at the Taegye (KI3) acupoints three times per week for 2 weeks. To evaluate the effects of EA treatment on cognitive functions, novel object recognition and Y-maze tests were performed with non-Tg, 5XFAD (Tg), and EA-treated 5XFAD (Tg + KI3) mice. To examine the molecular mechanisms underlying EA effects, western blots, immunohistochemistry, and micro-positron emission tomography scans were performed. Furthermore, we studied synapse ultrastructures with transmission electron microscopy and used electrophysiology to investigate EA effects on synaptic plasticity in 5XFAD mice. RESULTS: EA treatment significantly improved working memory and synaptic plasticity, alleviated neuroinflammation, and reduced ultrastructural degradation of synapses via upregulation of synaptophysin and postsynaptic density-95 protein in 5XFAD mice. Furthermore, microglia-mediated Aβ deposition was reduced after EA treatment and coincided with a reduction in amyloid precursor protein. CONCLUSIONS: Our findings demonstrate that EA treatment ameliorates cognitive impairment via inhibition of synaptic degeneration and neuroinflammation in a mouse model of AD.
38
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Holly D. Oakley, Sarah L. Cole, Sreemathi Logan et al. · Journal of Neuroscience · 2006 · 3.6K citations · Full text
Control of Synapse Number by Glia
Erik M. Ullian, Stephanie K. Sapperstein, Karen S. Christopherson et al. · Science · 2001 · 1.4K citations
Medicine, Neurobiology, Neuroscience +17